Upstream / Downstream
Explore pathways related to this product.
Important Ordering DetailsCustom Ordering Details: This product is assembled upon order. Please allow up to three weeks for your product to be processed
Pricing & Additional Information
To learn more about our Blocking Peptides, including pricing, please answer a few questions.
Find answers on our FAQs page.
PTM information and tools available.
Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Blocking Peptide #1010
Western blot analysis of Acetyl- and Phospho-Histone H3 (Lys9/Ser10) in control and serum, calyculin A and TSA treated NIH/3T3 cell extracts of Acetyl- and Phospho-Histone H3 (Lys9/Ser10) #9711 alone (left) and the same antibody preincubated with Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Blocking Peptide (right).Learn more about how we get our images
Immunohistochemical staining of paraffin-embedded human breast carcinoma, using Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Antibody #9711 preincubated with irrelevant control peptide (left) and Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Blocking Peptide (right).Learn more about how we get our images
Gallery: Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Blocking Peptide #1010
This peptide is used to block Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Antibody #9711 reactivity.
The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Antibody #9711 by immunohistochemistry and Western Blotting.
Use as a blocking reagent to evaluate the specificity of antibody reactivity in immunohistochemistry and Western blot protocols. For immunohistochemistry, add twice the volume of peptide as volume of antibody used in 100 µl total volume. Incubate for a minimum of 30 minutes prior to adding the entire volume to the slide. Recommended antibody dilutions can be found on the relevant product data sheet.
For Western immunoblotting, add 10 µl of antibody and 10 µl of blocking peptide to 10 ml of antibody dilution buffer, and incubate at room
temperature for 30 minutes before allowing to react with the blot.Storage: Supplied in 20 mM potassium phosphate (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 1 mg/ml BSA and 5% glycerol. Store at –20°C.
Modulation of chromatin structure plays an important role in the regulation of transcription in eukaryotes. The nucleosome, made up of DNA wound around eight core histone proteins (two each of H2A, H2B, H3, and H4), is the primary building block of chromatin (1). The amino-terminal tails of core histones undergo various post-translational modifications, including acetylation, phosphorylation, methylation, and ubiquitination (2-5). These modifications occur in response to various stimuli and have a direct effect on the accessibility of chromatin to transcription factors and, therefore, gene expression (6). In most species, histone H2B is primarily acetylated at Lys5, 12, 15, and 20 (4,7). Histone H3 is primarily acetylated at Lys9, 14, 18, 23, 27, and 56. Acetylation of H3 at Lys9 appears to have a dominant role in histone deposition and chromatin assembly in some organisms (2,3). Phosphorylation at Ser10, Ser28, and Thr11 of histone H3 is tightly correlated with chromosome condensation during both mitosis and meiosis (8-10). Phosphorylation at Thr3 of histone H3 is highly conserved among many species and is catalyzed by the kinase haspin. Immunostaining with phospho-specific antibodies in mammalian cells reveals mitotic phosphorylation at Thr3 of H3 in prophase and its dephosphorylation during anaphase (11).
For Research Use Only. Not For Use In Diagnostic Procedures. Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.